Chemomab Therapeutics Cash Flow Statement (2017-2025) | CMMB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)		-0.00B	-0.00B	-0.01B	-0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.02B			0.00B	-0.02B
Depreciation and Depletion (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Share-based Compensation (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Gains from Investment Securities (Quarter)				0.02B
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)	0.00B	-0.00B	0.00B		0.00B	0.00B	0.00B		0.00B
Change in Working Capital (Quarter)
Cash from Operations (Quarter)	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B
Depreciation, Depletion & Amortization
Amortization (Quarter)							0.00B				-0.00B					377.13B				625.68B
Depreciation & Amortization (CF) (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B
Change in Accured Expenses (Quarter)	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B
Other Working Capital Changes (Quarter)	-0.00B	0.00B		-0.00B	0.00B	-0.00B		0.00B	-0.00B	0.00B	-0.00B	-0.00B
Investing Activities
Capital Expenditures (Quarter)	0.00B	0.00B		0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B		0.00B
Sales of Property, Plant and Equipment (Quarter)
Cash from Investing Activities (Quarter)	-0.00B	-0.02B	-0.01B	-0.02B	0.00B	0.00B	0.01B	0.01B	0.01B	-0.00B	0.00B	0.00B
Financing Activities
Other financing activities (Quarter)	0.00B	0.00B	0.00B	-0.00B			0.01B	-0.01B		0.10B	0.10B	-0.01B	0.11B	0.11B	0.12B	0.12B	0.12B	0.12B	0.12B
Cash from Financing Activities (Quarter)	0.05B	0.01B	-0.00B	-0.00B		0.00B	0.00B	-0.00B		0.00B	0.00B	0.00B
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	0.05B	-0.01B	-0.01B	-0.02B	-0.00B	-0.00B	0.00B	0.00B	0.01B	-0.01B	-0.00B	0.00B
Free Cash Flow (Quarter)	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B
Net Cash Flow (Quarter)	0.05B	-0.01B	-0.01B	-0.02B	-0.00B	-0.00B	0.00B	0.00B	0.01B	-0.01B	-0.00B	0.00B

Research Tools

Chemomab Therapeutics Cash Flow Statement (2017-2025) | CMMB

Create an account

Sign In

Reset Password